Related Experiment Video
Updated: Sep 2, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
Yun Tien1, Hsiang-Ping Huang2, Ding-Lieh Liao3
1Department of Psychiatry, Taoyuan Psychiatric Center, Taoyuan City, Taiwan (ROC).
Background:
Aripiprazole is a third-generation antipsychotic agent with acceptable efficacy and a good safety profile. Previous studies have indicated the therapeutic serum concentration of aripiprazole to be 100 to 350 ng/ml; however, most of these studies examined a Western population. Patients with schizophrenia from Tungs' Taichung MetroHarbor Hospital in central Taiwan were recruited to analyze the dose-response relationship of aripiprazole in the Chinese population.
Objective:
We aimed to investigate whether a serum concentration of aripiprazole higher than the current suggested range leads to higher response rates.
Design:
A prospective cohort study was designed to investigate the response rates in different studied cohorts grouped by serum concentration of aripiprazole.
Data Sources And Methods:
Data of 64 patients who presented to a single medical center in central Taiwan and who received therapeutic drug monitoring (TDM) were obtained. Serum concentrations of aripiprazole were correlated with the clinical response of patients by using the Clinical Global Impressions (CGI) scores.
Results:
The mean concentration of aripiprazole was 432.1 ± 275.1 ng/ml in the study cohort. Among the much-improved patients, the mean serum concentration of aripiprazole was 494 ± 273 ng/ml (25th-75th percentiles 264-666 ng/ml), which was higher than the current recommended therapeutic target of 100-350 ng/ml for aripiprazole. The response rate in the severe group (baseline CGI score of 6 or 7) was significantly higher than in the moderate group (baseline CGI score of 4 or 5; 86.7% versus 55.9%, p = 0.007).
Conclusion:
A significantly higher response rate was observed in the study cohort with serum aripiprazole concentrations over 300 ng/ml. Therefore, dosing higher than the current recommended range may potentially improve the treatment efficacy in the Chinese population. Because the serum concentration varies among patients due to multiple intrinsic and extrinsic factors, TDM, especially in outpatients, is recommended if the clinical response is limited.
More Related Videos
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Dose-Response Relationship: Potency and Efficacy
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Dose-Response Relationship: Overview

